Cargando…

High Prevalence of Depressive Symptoms Among Ugandan Patients with Rheumatoid Arthritis

BACKGROUND: There is a scarcity of data on the burden of depression among Ugandans with rheumatoid arthritis (RA) patients. We aimed to screen for symptoms of depression, their severity and associated factors among patients with RA in Uganda. PATIENTS AND METHODS: A descriptive, cross-sectional stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Bongomin, Felix, Natukunda, Barbra, Sekimpi, Maria, Olum, Ronald, Baluku, Joseph Baruch, Makhoba, Anthony, Kaddumukasa, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106476/
https://www.ncbi.nlm.nih.gov/pubmed/33976574
http://dx.doi.org/10.2147/OARRR.S306503
_version_ 1783689786522861568
author Bongomin, Felix
Natukunda, Barbra
Sekimpi, Maria
Olum, Ronald
Baluku, Joseph Baruch
Makhoba, Anthony
Kaddumukasa, Mark
author_facet Bongomin, Felix
Natukunda, Barbra
Sekimpi, Maria
Olum, Ronald
Baluku, Joseph Baruch
Makhoba, Anthony
Kaddumukasa, Mark
author_sort Bongomin, Felix
collection PubMed
description BACKGROUND: There is a scarcity of data on the burden of depression among Ugandans with rheumatoid arthritis (RA) patients. We aimed to screen for symptoms of depression, their severity and associated factors among patients with RA in Uganda. PATIENTS AND METHODS: A descriptive, cross-sectional study was conducted between September and December 2020 at Mulago National Referral Hospital (MNRH) and Nsambya Hospital. Patients with RA were enrolled consecutively. Data on demographics, disease course and comorbidities and depression symptomatology were collected through an interviewer administered questionnaire. Symptoms of depression were screened for using the depression/anxiety dimension of the EuroQoL questionnaire. RESULTS: Forty-eight patients with a median age of 52 (IQR: 43.5–60.5) years were recruited in the study. The majority of the patients were female (91.7%, n=44). Twenty-nine patients (60.4%) had comorbidities with a median Charlson comorbidity score of 3 (IQR: 2–4). Overall, 70.8% (n=34) had depressive symptoms. Patients attending MNRH were more likely to have depressive symptoms (p=0.025). Significantly, patients with depressive symptoms were younger (p=0.027), had lower health index value (p<0.001), and lower overall self-reported health status (p=0.013). At binary logistic regression, patients at MNRH (crude odds ratio (COR): 4.32, 95% confidence interval (CI): 1.16–16.15, P=0.030), patients aged <52 years (COR: 5.24, 95% CI: 1.23–22.28, P=0.025) and those with mild RA (COR: 5.71, 95% CI: 1.15–28.35, P=0.033) were significantly more likely to have depressive symptoms. Increase in age (COR: 0.94, 95% CI: 0.89–0.99, P=0.025), and high visual analogue score (COR: 0.94, 95% CI: 0.89–0.99, P=0.013) were protective. CONCLUSION: Depressive symptoms were common among RA patients in Uganda. Routine screening, diagnosis and management of depression is recommended among young patients to improve quality of life and patient outcomes.
format Online
Article
Text
id pubmed-8106476
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81064762021-05-10 High Prevalence of Depressive Symptoms Among Ugandan Patients with Rheumatoid Arthritis Bongomin, Felix Natukunda, Barbra Sekimpi, Maria Olum, Ronald Baluku, Joseph Baruch Makhoba, Anthony Kaddumukasa, Mark Open Access Rheumatol Original Research BACKGROUND: There is a scarcity of data on the burden of depression among Ugandans with rheumatoid arthritis (RA) patients. We aimed to screen for symptoms of depression, their severity and associated factors among patients with RA in Uganda. PATIENTS AND METHODS: A descriptive, cross-sectional study was conducted between September and December 2020 at Mulago National Referral Hospital (MNRH) and Nsambya Hospital. Patients with RA were enrolled consecutively. Data on demographics, disease course and comorbidities and depression symptomatology were collected through an interviewer administered questionnaire. Symptoms of depression were screened for using the depression/anxiety dimension of the EuroQoL questionnaire. RESULTS: Forty-eight patients with a median age of 52 (IQR: 43.5–60.5) years were recruited in the study. The majority of the patients were female (91.7%, n=44). Twenty-nine patients (60.4%) had comorbidities with a median Charlson comorbidity score of 3 (IQR: 2–4). Overall, 70.8% (n=34) had depressive symptoms. Patients attending MNRH were more likely to have depressive symptoms (p=0.025). Significantly, patients with depressive symptoms were younger (p=0.027), had lower health index value (p<0.001), and lower overall self-reported health status (p=0.013). At binary logistic regression, patients at MNRH (crude odds ratio (COR): 4.32, 95% confidence interval (CI): 1.16–16.15, P=0.030), patients aged <52 years (COR: 5.24, 95% CI: 1.23–22.28, P=0.025) and those with mild RA (COR: 5.71, 95% CI: 1.15–28.35, P=0.033) were significantly more likely to have depressive symptoms. Increase in age (COR: 0.94, 95% CI: 0.89–0.99, P=0.025), and high visual analogue score (COR: 0.94, 95% CI: 0.89–0.99, P=0.013) were protective. CONCLUSION: Depressive symptoms were common among RA patients in Uganda. Routine screening, diagnosis and management of depression is recommended among young patients to improve quality of life and patient outcomes. Dove 2021-05-04 /pmc/articles/PMC8106476/ /pubmed/33976574 http://dx.doi.org/10.2147/OARRR.S306503 Text en © 2021 Bongomin et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Bongomin, Felix
Natukunda, Barbra
Sekimpi, Maria
Olum, Ronald
Baluku, Joseph Baruch
Makhoba, Anthony
Kaddumukasa, Mark
High Prevalence of Depressive Symptoms Among Ugandan Patients with Rheumatoid Arthritis
title High Prevalence of Depressive Symptoms Among Ugandan Patients with Rheumatoid Arthritis
title_full High Prevalence of Depressive Symptoms Among Ugandan Patients with Rheumatoid Arthritis
title_fullStr High Prevalence of Depressive Symptoms Among Ugandan Patients with Rheumatoid Arthritis
title_full_unstemmed High Prevalence of Depressive Symptoms Among Ugandan Patients with Rheumatoid Arthritis
title_short High Prevalence of Depressive Symptoms Among Ugandan Patients with Rheumatoid Arthritis
title_sort high prevalence of depressive symptoms among ugandan patients with rheumatoid arthritis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106476/
https://www.ncbi.nlm.nih.gov/pubmed/33976574
http://dx.doi.org/10.2147/OARRR.S306503
work_keys_str_mv AT bongominfelix highprevalenceofdepressivesymptomsamongugandanpatientswithrheumatoidarthritis
AT natukundabarbra highprevalenceofdepressivesymptomsamongugandanpatientswithrheumatoidarthritis
AT sekimpimaria highprevalenceofdepressivesymptomsamongugandanpatientswithrheumatoidarthritis
AT olumronald highprevalenceofdepressivesymptomsamongugandanpatientswithrheumatoidarthritis
AT balukujosephbaruch highprevalenceofdepressivesymptomsamongugandanpatientswithrheumatoidarthritis
AT makhobaanthony highprevalenceofdepressivesymptomsamongugandanpatientswithrheumatoidarthritis
AT kaddumukasamark highprevalenceofdepressivesymptomsamongugandanpatientswithrheumatoidarthritis